Insmed Inc header image

Insmed Inc

INSM

Equity

ISIN null / Valor 12614415

NASDAQ (2026-10-29)
USD 111.59+15.1%

Insmed Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Insmed Incorporated is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare and severe diseases, particularly targeting pulmonary conditions. The company's portfolio includes inhaled pharmaceuticals designed to treat various lung diseases, and it has expanded its pipeline through strategic acquisitions, such as Celtrix Pharmaceuticals, and partnerships like a worldwide license agreement with AstraZeneca. Following its transition to a public company, Insmed continues to advance clinical programs across its four strategic pillars, aiming to deliver meaningful clinical data and address unmet medical needs in the rare disease sector. Headquartered in Bridgewater, New Jersey, Insmed leverages its expertise and collaborative efforts to drive growth and enhance its position in the specialized pharmaceutical market.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-33.2%1Y
367%3Y
270%5Y

Performance

61.6%1Y
67.8%3Y
62.0%5Y

Volatility

Market cap

24369 M

Market cap (USD)

Daily traded volume (Shares)

11,220,668

Daily traded volume (Shares)

1 day high/low

69.6 / 67.75

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.27%USD 30.19
Inventiva SA
Inventiva SA Inventiva SA Valor: 35598121
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.36%EUR 3.35
Venture Life Group PLC
Venture Life Group PLC Venture Life Group PLC Valor: 23084203
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.26%GBP 0.68
Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.59%USD 36.88
McKesson Corp
McKesson Corp McKesson Corp Valor: 991041
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.12%USD 980.88
Vita 34 AG
Vita 34 AG Vita 34 AG Valor: 2333201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 2.79
Ambea AB
Ambea AB Ambea AB Valor: 36138415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.50%SEK 183.30
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.10%USD 37.52
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.80%EUR 0.66
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.43%USD 275.06